Cancer and ageing
Human evidence and active trials are visible in this field
515 human-evidence records · 160 active trials · 560 visible funding records · 6,594 universities
Australian Patent Application
Therapeutic applications of p53 isoforms in regenerative medicine aging and cancer
Source-linked patent metadata for Therapeutic applications of p53 isoforms in regenerative medicine aging and cancer, including priority, record stage and longevity-topic connections.
Australian application snapshot
Patent application record
This privacy-minimal view describes one official Australian patent application record. It is not presented as a complete worldwide patent family.
- Application number
- AU2008321253
- Earliest priority
- November 12, 2007
- Application date
- May 10, 2010
- Source record
- 1
- Patent offices
- 1
Patent-to-Evidence Translation Map
What is happening in the same scientific field?
These connections share a longevity topic with this patent record. They do not prove that the listed evidence, trials, funders, or universities validate, finance, own, or support this invention.
Regenerative medicine
Human evidence is visible; an active trial pathway is not yet visible
4 human-evidence records · 0 active trials · 41 visible funding records · 6,637 universities
Why names are absent
This feed intentionally excludes party names and contact details to minimise personal data. Open the official record when a name is consequential.
Topics connected by metadata
Cancer and ageing82% metadata match
Regenerative medicine82% metadata match
How the patent office classifies this invention
A61K31/7105 · A61K31/711 · A61K31/713 · A61P35/00 · C12N15/113
Verify in the original patent source →